Overview

An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder

Status:
Withdrawn
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate how effective mood stabilizers are in the treatment of bipolar disorder with comorbid alcoholism
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
University of California, Los Angeles
Treatments:
Ethanol
Olanzapine
Valproic Acid